Press release
Emerging Trends Influencing The Growth Of The Tuberculosis Therapeutics Market: Advancements In Tuberculosis Therapeutics For Drug Resistance
Tuberculosis Therapeutics
How Big Is the Tuberculosis Therapeutics Market Size Expected to Be by 2034?
The market size for tuberculosis treatment has been expanding notably in the recent past. It is projected to rise from $1.88 billion in 2024 to $2.01 billion in 2025, with a compound annual growth rate (CAGR) of 6.58%. The growth during the historical period can be linked to factors such as the escalating rate of tuberculosis cases, growing usage of tuberculosis therapies, heightened awareness of tuberculosis (TB), rising rates of XDR-TB, and an increase in occurrences of drug-resistant tuberculosis.
Expectations are high for a robust expansion of the tuberculosis therapeutics market in the coming years, with projections indicating it reaching a value of $2.57 billion by 2029. This corresponds to a compound annual growth rate (CAGR) of 6.32%. This trend is driven by several factors including increased spending on healthcare systems, heightened awareness and education about tuberculosis, a surge in funding for research and development, a rise in approvals for a variety of anti-TB drugs, substantial research financing, and the growing ageing population. Key trends expected within the forecast period involve progress in medicinal development, individualised treatments, combination therapies, the use of digital health technologies, and the application of AI and machine learning in discovering new drugs.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20983
What Are the Emerging Segments Within the Tuberculosis Therapeutics Market?
The tuberculosis therapeutics market covered in this report is segmented -
1) By Type: Active Tuberculosis (TB), Latent Tuberculosis (TB)
2) By Product Type: Isoniazid, Rifampin, Pyrazinamide, Hydrazine derivatives, Miscellaneous anti-tubercular drugs, Ethambutol
3) By Route of Administration: Oral, Parenteral, Other route of administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Active Tuberculosis (TB): First-Line Drugs (Rifampicin, Isoniazid, Pyrazinamide, Ethambutol), Second-Line Drugs (Fluoroquinolones, Aminoglycosides), Combination Therapies, Drug-Resistant TB Treatments (MDR-TB, XDR-TB)
2) By Latent Tuberculosis (TB): Isoniazid Prophylaxis, Rifampicin-Based Regimens, Rifapentine-Based Regimens, Combination Prophylactic Therapies
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20983&type=smp
What Long-Term Drivers Are Shaping Tuberculosis Therapeutics Market Trends?
The tuberculosis therapeutics market is predicted to experience growth fuelled by rising instances of co-infection rates (TB-HIV). The term co-infection rates (TB-HIV) pertains to the proportion of individuals simultaneously suffering from tuberculosis (TB) and the human immunodeficiency virus (HIV). The increase in co-infection rates (TB-HIV) can be linked to the immune system's vulnerability caused by HIV, which increases susceptibility to tuberculosis. This vulnerability is increased due to the simultaneous global epidemic of TB and HIV in populations at higher risk. The job of tuberculosis therapeutics is to address these increasing co-infection rates (TB-HIV) by providing specialised treatments tackling both TB and the immune suppression related to HIV. This contributes to superior patient outcomes and decreases the impact of both diseases. For example, the UK public sector organisation, gov.uk reported in October 2023 that England had marked 3,805 new HIV diagnoses in 2022, reflecting a 22% increase from the 3,118 cases reported in 2021. Consequently, the escalating rates of co-infection (TB-HIV) are promoting the growth of the tuberculosis therapeutics market.
Who Are the Top Competitors in Key Tuberculosis Therapeutics Market Segments?
Major companies operating in the tuberculosis therapeutics market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Macleods Pharmaceuticals Ltd., Cipla Limited, Hikma Pharmaceuticals plc, Lupin Limited, Alkem Laboratories Limited, Emcure Pharmaceuticals Limited, Otsuka Pharmaceutical Co. Ltd., Sequella Inc.
What Actigraphy Devices Market Trends Are Gaining Traction Across Different Segments?
Key players in the tuberculosis therapeutics market are concentrating on developing innovative solutions such as combination therapy. This strategy seeks to enhance the effectiveness of treatment, shorten the duration of therapy, and deal with tuberculosis strains resistant to drugs. Combination therapy leverages two or more drugs from various classes to fight disease, with goals of elevated treatment efficacy, curtailed resistance, and better patient results. For example, Johnson & Johnson, a pharmaceutical company based in the US, made a notable advancement in tuberculosis treatment in July 2024. The company secured approval by the U.S. FDA and the European Commission for SIRTURO (bedaquiline), the first drug purposefully created to manage multidrug-resistant tuberculosis (MDR-TB) in over forty years. This innovative drug functions by inhibiting the ATP synthase enzyme critical for TB bacteria's energy production, providing a targeted and effective treatment method. When added to combination therapies, it boosts the overall potency of MDR-TB regimens, decreases the duration of treatment, and enhances patient adherence.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/tuberculosis-therapeutics-global-market-report
Which Regions Are Becoming Hubs for Tuberculosis Therapeutics Market Innovation?
North America was the largest region in the tuberculosis therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tuberculosis therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Tuberculosis Therapeutics Market?
2. What is the CAGR expected in the Tuberculosis Therapeutics Market?
3. What Are the Key Innovations Transforming the Tuberculosis Therapeutics Industry?
4. Which Region Is Leading the Tuberculosis Therapeutics Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Emerging Trends Influencing The Growth Of The Tuberculosis Therapeutics Market: Advancements In Tuberculosis Therapeutics For Drug Resistance here
News-ID: 4069439 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Tuberculosis
Revolutionizing the Fight Against Tuberculosis: Global Anti-Tuberculosis Therape …
The global Anti-Tuberculosis (TB) Therapeutics Market is on the cusp of a transformative era, driven by urgent medical need, groundbreaking scientific advances, and expanding public-private partnerships. With an estimated 10 million new TB cases reported worldwide in 2022 and 1.4 million deaths, tuberculosis remains a leading infectious disease killer, commanding critical attention from healthcare providers, governments, and pharmaceutical innovators alike. As the world rallies to eliminate this centuries-old scourge, the…
Latent Tuberculosis Infection Detection Market
Latent Tuberculosis Infection Detection Market worth $2.37 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Latent Tuberculosis Infection Detection Market - (By Brand (QFT-Plus), By Test Type (Tuberculin Skin Test (TST), Interferon Gamma Release Assay (IGRA)), By Application, By End-use), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research…
Tuberculosis (TB) Diagnostics Market - Detect, Diagnose, Defeat: Innovating Solu …
Newark, New Castle, USA - new report, titled Tuberculosis (TB) Diagnostics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Tuberculosis (TB) Diagnostics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Tuberculosis (TB) Diagnostics market. The report offers an overview of…
Conquering Tuberculosis: Exploring the Innovations in Mycobacterium Tuberculosis …
The global mycobacterium tuberculosis treatment market was valued at US$ 1.97 Bn in 2021 and is expected to increase at a CAGR of 1.2% over the forecast period 2022-2032.
Mycobacterium tuberculosis is a bacteria that causes tuberculosis (TB), which mostly affects the lungs. Tuberculosis is a major public health crisis concern; however, it can be cured and prevented. Adults are most often affected by tuberculosis during their most productive years. Over…
World Tuberculosis Day - Tuberculosis, the invisible pandemic
Tuberculosis is a disease that, every year, kills as many as COVID-19 does.
March 24, World Tuberculosis Day, marks the anniversary of a momentous occasion - the discovery of the bacterium which causes tuberculosis in 1882. More than a hundred years after its discovery, tuberculosis is still a global health crisis. It is the leading cause of death from a single infectious disease agent, killing close to as many people per…
Ocular Tuberculosis Therapeutics Market To Expand On Account Of Rising Tuberculo …
Research Nester released a report titled “Ocular Tuberculosis Therapeutics Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global ocular tuberculosis therapeutics market in terms of market segmentation by treatment, by end user and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
Ocular tuberculosis is a type…
